Viemed Healthcare, Inc. (NASDAQ: VMD) Stock Competitors & Peer Comparison
See VMD's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Medical - Care Facilities Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for VMD and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| VMD | $8.84 | -1.90% | 345.8M | 25.22 | $0.36 | N/A |
| HCA | $401.46 | -1.89% | 87.7B | 13.98 | $28.96 | +0.74% |
| THC | $260.11 | -1.28% | 21.3B | 15.37 | $17.24 | N/A |
| FMS | $22.51 | +0.16% | 12.2B | 8.52 | $2.66 | +3.81% |
| EHC | $121.08 | -1.24% | 12.1B | 20.85 | $5.84 | +0.62% |
| DVA | $181.48 | -0.10% | 11.8B | 14.37 | $12.80 | N/A |
| UHS | $171.12 | +1.13% | 10.3B | 7.53 | $22.54 | +0.47% |
| ENSG | $171.56 | -0.31% | 10B | 24.75 | $6.90 | +0.15% |
| OSH | $39.00 | +0.08% | 9.5B | -17.65 | -$2.21 | N/A |
| CHE | $521.66 | -0.53% | 6.8B | 24.06 | $21.61 | +0.48% |
Stock Comparison
HCA Healthcare, Inc. (NYSE: HCA)
VMD vs HCA Comparison September 2026
Viemed Healthcare, Inc. (NASDAQ: VMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMD stands at 345.8M. In comparison, HCA has a market cap of 87.7B. Regarding current trading prices, VMD is priced at $8.84 on the NASDAQ, while HCA trades at $401.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMD currently has a P/E ratio of 25.22, whereas HCA's P/E ratio is 13.98. In terms of profitability, VMD's ROE is +0.10%, compared to HCA's ROE of -1.13%. Regarding short-term risk, VMD is less volatile compared to HCA. This indicates lower risk in terms of short-term price fluctuations for VMD.Check HCA's competition here
Tenet Healthcare Corporation (NYSE: THC)
VMD vs THC Comparison September 2026
Viemed Healthcare, Inc. (NASDAQ: VMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMD stands at 345.8M. In comparison, THC has a market cap of 21.3B. Regarding current trading prices, VMD is priced at $8.84 on the NASDAQ, while THC trades at $260.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMD currently has a P/E ratio of 25.22, whereas THC's P/E ratio is 15.37. In terms of profitability, VMD's ROE is +0.10%, compared to THC's ROE of +0.51%. Regarding short-term risk, VMD is less volatile compared to THC. This indicates lower risk in terms of short-term price fluctuations for VMD.Check THC's competition here
Fresenius Medical Care AG & Co. KGaA (NYSE: FMS)
VMD vs FMS Comparison September 2026
Viemed Healthcare, Inc. (NASDAQ: VMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMD stands at 345.8M. In comparison, FMS has a market cap of 12.2B. Regarding current trading prices, VMD is priced at $8.84 on the NASDAQ, while FMS trades at $22.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMD currently has a P/E ratio of 25.22, whereas FMS's P/E ratio is 8.52. In terms of profitability, VMD's ROE is +0.10%, compared to FMS's ROE of +0.07%. Regarding short-term risk, VMD is more volatile compared to FMS. This indicates higher risk in terms of short-term price fluctuations for VMD.Check FMS's competition here
Encompass Health Corporation (NYSE: EHC)
VMD vs EHC Comparison September 2026
Viemed Healthcare, Inc. (NASDAQ: VMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMD stands at 345.8M. In comparison, EHC has a market cap of 12.1B. Regarding current trading prices, VMD is priced at $8.84 on the NASDAQ, while EHC trades at $121.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMD currently has a P/E ratio of 25.22, whereas EHC's P/E ratio is 20.85. In terms of profitability, VMD's ROE is +0.10%, compared to EHC's ROE of +0.25%. Regarding short-term risk, VMD is more volatile compared to EHC. This indicates higher risk in terms of short-term price fluctuations for VMD.Check EHC's competition here
DaVita Inc. (NYSE: DVA)
VMD vs DVA Comparison September 2026
Viemed Healthcare, Inc. (NASDAQ: VMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMD stands at 345.8M. In comparison, DVA has a market cap of 11.8B. Regarding current trading prices, VMD is priced at $8.84 on the NASDAQ, while DVA trades at $181.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMD currently has a P/E ratio of 25.22, whereas DVA's P/E ratio is 14.37. In terms of profitability, VMD's ROE is +0.10%, compared to DVA's ROE of -1.24%. Regarding short-term risk, VMD is more volatile compared to DVA. This indicates higher risk in terms of short-term price fluctuations for VMD.Check DVA's competition here
Universal Health Services, Inc. (NYSE: UHS)
VMD vs UHS Comparison September 2026
Viemed Healthcare, Inc. (NASDAQ: VMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMD stands at 345.8M. In comparison, UHS has a market cap of 10.3B. Regarding current trading prices, VMD is priced at $8.84 on the NASDAQ, while UHS trades at $171.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMD currently has a P/E ratio of 25.22, whereas UHS's P/E ratio is 7.53. In terms of profitability, VMD's ROE is +0.10%, compared to UHS's ROE of +0.21%. Regarding short-term risk, VMD is less volatile compared to UHS. This indicates lower risk in terms of short-term price fluctuations for VMD.Check UHS's competition here
The Ensign Group, Inc. (NASDAQ: ENSG)
VMD vs ENSG Comparison September 2026
Viemed Healthcare, Inc. (NASDAQ: VMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMD stands at 345.8M. In comparison, ENSG has a market cap of 10B. Regarding current trading prices, VMD is priced at $8.84 on the NASDAQ, while ENSG trades at $171.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMD currently has a P/E ratio of 25.22, whereas ENSG's P/E ratio is 24.75. In terms of profitability, VMD's ROE is +0.10%, compared to ENSG's ROE of +0.17%. Regarding short-term risk, VMD is more volatile compared to ENSG. This indicates higher risk in terms of short-term price fluctuations for VMD.Check ENSG's competition here
Oak Street Health, Inc. (NYSE: OSH)
VMD vs OSH Comparison September 2026
Viemed Healthcare, Inc. (NASDAQ: VMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMD stands at 345.8M. In comparison, OSH has a market cap of 9.5B. Regarding current trading prices, VMD is priced at $8.84 on the NASDAQ, while OSH trades at $39.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMD currently has a P/E ratio of 25.22, whereas OSH's P/E ratio is -17.65. In terms of profitability, VMD's ROE is +0.10%, compared to OSH's ROE of +4.64%. Regarding short-term risk, VMD is more volatile compared to OSH. This indicates higher risk in terms of short-term price fluctuations for VMD.Check OSH's competition here
Chemed Corporation (NYSE: CHE)
VMD vs CHE Comparison September 2026
Viemed Healthcare, Inc. (NASDAQ: VMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMD stands at 345.8M. In comparison, CHE has a market cap of 6.8B. Regarding current trading prices, VMD is priced at $8.84 on the NASDAQ, while CHE trades at $521.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMD currently has a P/E ratio of 25.22, whereas CHE's P/E ratio is 24.06. In terms of profitability, VMD's ROE is +0.10%, compared to CHE's ROE of +0.29%. Regarding short-term risk, VMD is less volatile compared to CHE. This indicates lower risk in terms of short-term price fluctuations for VMD.Check CHE's competition here
PACS Group, Inc. (NYSE: PACS)
VMD vs PACS Comparison September 2026
Viemed Healthcare, Inc. (NASDAQ: VMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMD stands at 345.8M. In comparison, PACS has a market cap of 6.7B. Regarding current trading prices, VMD is priced at $8.84 on the NASDAQ, while PACS trades at $43.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMD currently has a P/E ratio of 25.22, whereas PACS's P/E ratio is 22.49. In terms of profitability, VMD's ROE is +0.10%, compared to PACS's ROE of +0.27%. Regarding short-term risk, VMD is less volatile compared to PACS. This indicates lower risk in terms of short-term price fluctuations for VMD.Check PACS's competition here
Hims & Hers Health, Inc. (NYSE: HIMS)
VMD vs HIMS Comparison September 2026
Viemed Healthcare, Inc. (NASDAQ: VMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMD stands at 345.8M. In comparison, HIMS has a market cap of 6.2B. Regarding current trading prices, VMD is priced at $8.84 on the NASDAQ, while HIMS trades at $27.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMD currently has a P/E ratio of 25.22, whereas HIMS's P/E ratio is -43.30. In terms of profitability, VMD's ROE is +0.10%, compared to HIMS's ROE of -0.30%. Regarding short-term risk, VMD is less volatile compared to HIMS. This indicates lower risk in terms of short-term price fluctuations for VMD.Check HIMS's competition here
LHC Group, Inc. (NASDAQ: LHCG)
VMD vs LHCG Comparison September 2026
Viemed Healthcare, Inc. (NASDAQ: VMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMD stands at 345.8M. In comparison, LHCG has a market cap of 5.3B. Regarding current trading prices, VMD is priced at $8.84 on the NASDAQ, while LHCG trades at $169.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMD currently has a P/E ratio of 25.22, whereas LHCG's P/E ratio is 82.83. In terms of profitability, VMD's ROE is +0.10%, compared to LHCG's ROE of +0.04%. Regarding short-term risk, VMD is more volatile compared to LHCG. This indicates higher risk in terms of short-term price fluctuations for VMD.Check LHCG's competition here
LifeStance Health Group, Inc. (NASDAQ: LFST)
VMD vs LFST Comparison September 2026
Viemed Healthcare, Inc. (NASDAQ: VMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMD stands at 345.8M. In comparison, LFST has a market cap of 4.9B. Regarding current trading prices, VMD is priced at $8.84 on the NASDAQ, while LFST trades at $12.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMD currently has a P/E ratio of 25.22, whereas LFST's P/E ratio is 95.88. In terms of profitability, VMD's ROE is +0.10%, compared to LFST's ROE of +0.03%. Regarding short-term risk, VMD is less volatile compared to LFST. This indicates lower risk in terms of short-term price fluctuations for VMD.Check LFST's competition here
Concentra Group Holdings Parent, Inc. (NYSE: CON)
VMD vs CON Comparison September 2026
Viemed Healthcare, Inc. (NASDAQ: VMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMD stands at 345.8M. In comparison, CON has a market cap of 4.4B. Regarding current trading prices, VMD is priced at $8.84 on the NASDAQ, while CON trades at $34.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMD currently has a P/E ratio of 25.22, whereas CON's P/E ratio is 21.68. In terms of profitability, VMD's ROE is +0.10%, compared to CON's ROE of +0.47%. Regarding short-term risk, VMD is more volatile compared to CON. This indicates higher risk in terms of short-term price fluctuations for VMD.Check CON's competition here
Option Care Health, Inc. (NASDAQ: OPCH)
VMD vs OPCH Comparison September 2026
Viemed Healthcare, Inc. (NASDAQ: VMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMD stands at 345.8M. In comparison, OPCH has a market cap of 3.6B. Regarding current trading prices, VMD is priced at $8.84 on the NASDAQ, while OPCH trades at $23.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMD currently has a P/E ratio of 25.22, whereas OPCH's P/E ratio is 14.08. In terms of profitability, VMD's ROE is +0.10%, compared to OPCH's ROE of +0.16%. Regarding short-term risk, VMD is more volatile compared to OPCH. This indicates higher risk in terms of short-term price fluctuations for VMD.Check OPCH's competition here
National HealthCare Corporation (AMEX: NHC)
VMD vs NHC Comparison September 2026
Viemed Healthcare, Inc. (NASDAQ: VMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMD stands at 345.8M. In comparison, NHC has a market cap of 3.4B. Regarding current trading prices, VMD is priced at $8.84 on the NASDAQ, while NHC trades at $221.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMD currently has a P/E ratio of 25.22, whereas NHC's P/E ratio is 27.82. In terms of profitability, VMD's ROE is +0.10%, compared to NHC's ROE of +0.13%. Regarding short-term risk, VMD is more volatile compared to NHC. This indicates higher risk in terms of short-term price fluctuations for VMD.Check NHC's competition here
Amedisys, Inc. (NASDAQ: AMED)
VMD vs AMED Comparison September 2026
Viemed Healthcare, Inc. (NASDAQ: VMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMD stands at 345.8M. In comparison, AMED has a market cap of 3.3B. Regarding current trading prices, VMD is priced at $8.84 on the NASDAQ, while AMED trades at $100.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMD currently has a P/E ratio of 25.22, whereas AMED's P/E ratio is 39.30. In terms of profitability, VMD's ROE is +0.10%, compared to AMED's ROE of +0.11%. Regarding short-term risk, VMD is more volatile compared to AMED. This indicates higher risk in terms of short-term price fluctuations for VMD.Check AMED's competition here
Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH)
VMD vs AVAH Comparison September 2026
Viemed Healthcare, Inc. (NASDAQ: VMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMD stands at 345.8M. In comparison, AVAH has a market cap of 3B. Regarding current trading prices, VMD is priced at $8.84 on the NASDAQ, while AVAH trades at $13.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMD currently has a P/E ratio of 25.22, whereas AVAH's P/E ratio is 19.97. In terms of profitability, VMD's ROE is +0.10%, compared to AVAH's ROE of +1.50%. Regarding short-term risk, VMD is less volatile compared to AVAH. This indicates lower risk in terms of short-term price fluctuations for VMD.Check AVAH's competition here
Brookdale Senior Living Inc. (NYSE: BKD)
VMD vs BKD Comparison September 2026
Viemed Healthcare, Inc. (NASDAQ: VMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMD stands at 345.8M. In comparison, BKD has a market cap of 2.8B. Regarding current trading prices, VMD is priced at $8.84 on the NASDAQ, while BKD trades at $12.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMD currently has a P/E ratio of 25.22, whereas BKD's P/E ratio is -20.29. In terms of profitability, VMD's ROE is +0.10%, compared to BKD's ROE of +4.06%. Regarding short-term risk, VMD is less volatile compared to BKD. This indicates lower risk in terms of short-term price fluctuations for VMD.Check BKD's competition here
Acadia Healthcare Company, Inc. (NASDAQ: ACHC)
VMD vs ACHC Comparison September 2026
Viemed Healthcare, Inc. (NASDAQ: VMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMD stands at 345.8M. In comparison, ACHC has a market cap of 2.6B. Regarding current trading prices, VMD is priced at $8.84 on the NASDAQ, while ACHC trades at $27.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMD currently has a P/E ratio of 25.22, whereas ACHC's P/E ratio is 14.14. In terms of profitability, VMD's ROE is +0.10%, compared to ACHC's ROE of -0.50%. Regarding short-term risk, VMD is less volatile compared to ACHC. This indicates lower risk in terms of short-term price fluctuations for VMD.Check ACHC's competition here
Guardian Pharmacy Services, Inc. (NYSE: GRDN)
VMD vs GRDN Comparison September 2026
Viemed Healthcare, Inc. (NASDAQ: VMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMD stands at 345.8M. In comparison, GRDN has a market cap of 2.6B. Regarding current trading prices, VMD is priced at $8.84 on the NASDAQ, while GRDN trades at $41.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMD currently has a P/E ratio of 25.22, whereas GRDN's P/E ratio is 35.76. In terms of profitability, VMD's ROE is +0.10%, compared to GRDN's ROE of +0.31%. Regarding short-term risk, VMD is less volatile compared to GRDN. This indicates lower risk in terms of short-term price fluctuations for VMD.Check GRDN's competition here
Pediatrix Medical Group, Inc. (NYSE: MD)
VMD vs MD Comparison September 2026
Viemed Healthcare, Inc. (NASDAQ: VMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMD stands at 345.8M. In comparison, MD has a market cap of 2.2B. Regarding current trading prices, VMD is priced at $8.84 on the NASDAQ, while MD trades at $26.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMD currently has a P/E ratio of 25.22, whereas MD's P/E ratio is 12.07. In terms of profitability, VMD's ROE is +0.10%, compared to MD's ROE of +0.20%. Regarding short-term risk, VMD is more volatile compared to MD. This indicates higher risk in terms of short-term price fluctuations for VMD.Check MD's competition here
Addus HomeCare Corporation (NASDAQ: ADUS)
VMD vs ADUS Comparison September 2026
Viemed Healthcare, Inc. (NASDAQ: VMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMD stands at 345.8M. In comparison, ADUS has a market cap of 2.2B. Regarding current trading prices, VMD is priced at $8.84 on the NASDAQ, while ADUS trades at $119.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMD currently has a P/E ratio of 25.22, whereas ADUS's P/E ratio is 17.78. In terms of profitability, VMD's ROE is +0.10%, compared to ADUS's ROE of +0.10%. Regarding short-term risk, VMD is more volatile compared to ADUS. This indicates higher risk in terms of short-term price fluctuations for VMD.Check ADUS's competition here
Select Medical Holdings Corporation (NYSE: SEM)
VMD vs SEM Comparison September 2026
Viemed Healthcare, Inc. (NASDAQ: VMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMD stands at 345.8M. In comparison, SEM has a market cap of 2B. Regarding current trading prices, VMD is priced at $8.84 on the NASDAQ, while SEM trades at $16.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMD currently has a P/E ratio of 25.22, whereas SEM's P/E ratio is 15.43. In terms of profitability, VMD's ROE is +0.10%, compared to SEM's ROE of +0.08%. Regarding short-term risk, VMD is more volatile compared to SEM. This indicates higher risk in terms of short-term price fluctuations for VMD.Check SEM's competition here
Astrana Health, Inc. (NASDAQ: ASTH)
VMD vs ASTH Comparison September 2026
Viemed Healthcare, Inc. (NASDAQ: VMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMD stands at 345.8M. In comparison, ASTH has a market cap of 1.9B. Regarding current trading prices, VMD is priced at $8.84 on the NASDAQ, while ASTH trades at $37.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMD currently has a P/E ratio of 25.22, whereas ASTH's P/E ratio is 46.35. In terms of profitability, VMD's ROE is +0.10%, compared to ASTH's ROE of +0.05%. Regarding short-term risk, VMD is more volatile compared to ASTH. This indicates higher risk in terms of short-term price fluctuations for VMD.Check ASTH's competition here
Surgery Partners, Inc. (NASDAQ: SGRY)
VMD vs SGRY Comparison September 2026
Viemed Healthcare, Inc. (NASDAQ: VMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMD stands at 345.8M. In comparison, SGRY has a market cap of 1.9B. Regarding current trading prices, VMD is priced at $8.84 on the NASDAQ, while SGRY trades at $14.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMD currently has a P/E ratio of 25.22, whereas SGRY's P/E ratio is 36.56. In terms of profitability, VMD's ROE is +0.10%, compared to SGRY's ROE of -0.05%. Regarding short-term risk, VMD is less volatile compared to SGRY. This indicates lower risk in terms of short-term price fluctuations for VMD.Check SGRY's competition here
Apollo Medical Holdings, Inc. (NASDAQ: AMEH)
VMD vs AMEH Comparison September 2026
Viemed Healthcare, Inc. (NASDAQ: VMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMD stands at 345.8M. In comparison, AMEH has a market cap of 1.8B. Regarding current trading prices, VMD is priced at $8.84 on the NASDAQ, while AMEH trades at $40.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMD currently has a P/E ratio of 25.22, whereas AMEH's P/E ratio is 39.25. In terms of profitability, VMD's ROE is +0.10%, compared to AMEH's ROE of +0.05%. Regarding short-term risk, VMD is less volatile compared to AMEH. This indicates lower risk in terms of short-term price fluctuations for VMD.Check AMEH's competition here
Sonida Senior Living, Inc. (NYSE: SNDA)
VMD vs SNDA Comparison September 2026
Viemed Healthcare, Inc. (NASDAQ: VMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMD stands at 345.8M. In comparison, SNDA has a market cap of 1.8B. Regarding current trading prices, VMD is priced at $8.84 on the NASDAQ, while SNDA trades at $39.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMD currently has a P/E ratio of 25.22, whereas SNDA's P/E ratio is -6.09. In terms of profitability, VMD's ROE is +0.10%, compared to SNDA's ROE of -0.26%. Regarding short-term risk, VMD is less volatile compared to SNDA. This indicates lower risk in terms of short-term price fluctuations for VMD.Check SNDA's competition here
Ardent Health Inc. (NYSE: ARDT)
VMD vs ARDT Comparison September 2026
Viemed Healthcare, Inc. (NASDAQ: VMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMD stands at 345.8M. In comparison, ARDT has a market cap of 1.6B. Regarding current trading prices, VMD is priced at $8.84 on the NASDAQ, while ARDT trades at $10.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMD currently has a P/E ratio of 25.22, whereas ARDT's P/E ratio is 8.80. In terms of profitability, VMD's ROE is +0.10%, compared to ARDT's ROE of +0.05%. Regarding short-term risk, VMD is less volatile compared to ARDT. This indicates lower risk in terms of short-term price fluctuations for VMD.Check ARDT's competition here
Healthcare Services Group, Inc. (NASDAQ: HCSG)
VMD vs HCSG Comparison September 2026
Viemed Healthcare, Inc. (NASDAQ: VMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMD stands at 345.8M. In comparison, HCSG has a market cap of 1.5B. Regarding current trading prices, VMD is priced at $8.84 on the NASDAQ, while HCSG trades at $21.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMD currently has a P/E ratio of 25.22, whereas HCSG's P/E ratio is 17.46. In terms of profitability, VMD's ROE is +0.10%, compared to HCSG's ROE of +0.24%. Regarding short-term risk, VMD is less volatile compared to HCSG. This indicates lower risk in terms of short-term price fluctuations for VMD.Check HCSG's competition here
Agilon Health, Inc. (NYSE: AGL)
VMD vs AGL Comparison September 2026
Viemed Healthcare, Inc. (NASDAQ: VMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMD stands at 345.8M. In comparison, AGL has a market cap of 1.5B. Regarding current trading prices, VMD is priced at $8.84 on the NASDAQ, while AGL trades at $90.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMD currently has a P/E ratio of 25.22, whereas AGL's P/E ratio is -5.74. In terms of profitability, VMD's ROE is +0.10%, compared to AGL's ROE of -1.19%. Regarding short-term risk, VMD is less volatile compared to AGL. This indicates lower risk in terms of short-term price fluctuations for VMD.Check AGL's competition here
Innovage Holding Corp. (NASDAQ: INNV)
VMD vs INNV Comparison September 2026
Viemed Healthcare, Inc. (NASDAQ: VMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMD stands at 345.8M. In comparison, INNV has a market cap of 1.5B. Regarding current trading prices, VMD is priced at $8.84 on the NASDAQ, while INNV trades at $10.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMD currently has a P/E ratio of 25.22, whereas INNV's P/E ratio is -119.44. In terms of profitability, VMD's ROE is +0.10%, compared to INNV's ROE of -0.09%. Regarding short-term risk, VMD is less volatile compared to INNV. This indicates lower risk in terms of short-term price fluctuations for VMD.Check INNV's competition here
Nutex Health, Inc. (NASDAQ: NUTX)
VMD vs NUTX Comparison September 2026
Viemed Healthcare, Inc. (NASDAQ: VMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMD stands at 345.8M. In comparison, NUTX has a market cap of 1.3B. Regarding current trading prices, VMD is priced at $8.84 on the NASDAQ, while NUTX trades at $191.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMD currently has a P/E ratio of 25.22, whereas NUTX's P/E ratio is 7.65. In terms of profitability, VMD's ROE is +0.10%, compared to NUTX's ROE of +0.52%. Regarding short-term risk, VMD is less volatile compared to NUTX. This indicates lower risk in terms of short-term price fluctuations for VMD.Check NUTX's competition here
The Pennant Group, Inc. (NASDAQ: PNTG)
VMD vs PNTG Comparison September 2026
Viemed Healthcare, Inc. (NASDAQ: VMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMD stands at 345.8M. In comparison, PNTG has a market cap of 1.3B. Regarding current trading prices, VMD is priced at $8.84 on the NASDAQ, while PNTG trades at $39.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMD currently has a P/E ratio of 25.22, whereas PNTG's P/E ratio is 28.79. In terms of profitability, VMD's ROE is +0.10%, compared to PNTG's ROE of +0.10%. Regarding short-term risk, VMD is less volatile compared to PNTG. This indicates lower risk in terms of short-term price fluctuations for VMD.Check PNTG's competition here
AMN Healthcare Services, Inc. (NYSE: AMN)
VMD vs AMN Comparison September 2026
Viemed Healthcare, Inc. (NASDAQ: VMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMD stands at 345.8M. In comparison, AMN has a market cap of 1.3B. Regarding current trading prices, VMD is priced at $8.84 on the NASDAQ, while AMN trades at $33.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMD currently has a P/E ratio of 25.22, whereas AMN's P/E ratio is 11.23. In terms of profitability, VMD's ROE is +0.10%, compared to AMN's ROE of +0.15%. Regarding short-term risk, VMD is less volatile compared to AMN. This indicates lower risk in terms of short-term price fluctuations for VMD.Check AMN's competition here
Brookdale Senior Living Inc. 7. (NYSE: BKDT)
VMD vs BKDT Comparison September 2026
Viemed Healthcare, Inc. (NASDAQ: VMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMD stands at 345.8M. In comparison, BKDT has a market cap of 1.2B. Regarding current trading prices, VMD is priced at $8.84 on the NASDAQ, while BKDT trades at $77.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMD currently has a P/E ratio of 25.22, whereas BKDT's P/E ratio is N/A. In terms of profitability, VMD's ROE is +0.10%, compared to BKDT's ROE of +4.06%. Regarding short-term risk, VMD is more volatile compared to BKDT. This indicates higher risk in terms of short-term price fluctuations for VMD.Check BKDT's competition here
U.S. Physical Therapy, Inc. (NYSE: USPH)
VMD vs USPH Comparison September 2026
Viemed Healthcare, Inc. (NASDAQ: VMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMD stands at 345.8M. In comparison, USPH has a market cap of 1.2B. Regarding current trading prices, VMD is priced at $8.84 on the NASDAQ, while USPH trades at $79.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMD currently has a P/E ratio of 25.22, whereas USPH's P/E ratio is 31.24. In terms of profitability, VMD's ROE is +0.10%, compared to USPH's ROE of -0.01%. Regarding short-term risk, VMD is more volatile compared to USPH. This indicates higher risk in terms of short-term price fluctuations for VMD.Check USPH's competition here
Talkspace, Inc. (NASDAQ: TALK)
VMD vs TALK Comparison September 2026
Viemed Healthcare, Inc. (NASDAQ: VMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMD stands at 345.8M. In comparison, TALK has a market cap of 879.4M. Regarding current trading prices, VMD is priced at $8.84 on the NASDAQ, while TALK trades at $5.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMD currently has a P/E ratio of 25.22, whereas TALK's P/E ratio is 774.34. In terms of profitability, VMD's ROE is +0.10%, compared to TALK's ROE of +0.00%. Regarding short-term risk, VMD is more volatile compared to TALK. This indicates higher risk in terms of short-term price fluctuations for VMD.Check TALK's competition here
GMR Solutions Inc. (NYSE: GMRS)
VMD vs GMRS Comparison September 2026
Viemed Healthcare, Inc. (NASDAQ: VMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMD stands at 345.8M. In comparison, GMRS has a market cap of 727M. Regarding current trading prices, VMD is priced at $8.84 on the NASDAQ, while GMRS trades at $13.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMD currently has a P/E ratio of 25.22, whereas GMRS's P/E ratio is 5.98. In terms of profitability, VMD's ROE is +0.10%, compared to GMRS's ROE of +0.16%. Regarding short-term risk, VMD is less volatile compared to GMRS. This indicates lower risk in terms of short-term price fluctuations for VMD.Check GMRS's competition here
Enhabit, Inc. (NYSE: EHAB)
VMD vs EHAB Comparison September 2026
Viemed Healthcare, Inc. (NASDAQ: VMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMD stands at 345.8M. In comparison, EHAB has a market cap of 706.9M. Regarding current trading prices, VMD is priced at $8.84 on the NASDAQ, while EHAB trades at $13.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMD currently has a P/E ratio of 25.22, whereas EHAB's P/E ratio is -197.14. In terms of profitability, VMD's ROE is +0.10%, compared to EHAB's ROE of -0.01%. Regarding short-term risk, VMD is more volatile compared to EHAB. This indicates higher risk in terms of short-term price fluctuations for VMD.Check EHAB's competition here
Starling Oncology, Inc. (NASDAQ: STLN)
VMD vs STLN Comparison September 2026
Viemed Healthcare, Inc. (NASDAQ: VMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMD stands at 345.8M. In comparison, STLN has a market cap of 592.9M. Regarding current trading prices, VMD is priced at $8.84 on the NASDAQ, while STLN trades at $6.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMD currently has a P/E ratio of 25.22, whereas STLN's P/E ratio is N/A. In terms of profitability, VMD's ROE is +0.10%, compared to STLN's ROE of +2.10%. Regarding short-term risk, VMD is less volatile compared to STLN. This indicates lower risk in terms of short-term price fluctuations for VMD.Check STLN's competition here
The Oncology Institute, Inc. (NASDAQ: TOI)
VMD vs TOI Comparison September 2026
Viemed Healthcare, Inc. (NASDAQ: VMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMD stands at 345.8M. In comparison, TOI has a market cap of 512.9M. Regarding current trading prices, VMD is priced at $8.84 on the NASDAQ, while TOI trades at $5.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMD currently has a P/E ratio of 25.22, whereas TOI's P/E ratio is -14.25. In terms of profitability, VMD's ROE is +0.10%, compared to TOI's ROE of +2.10%. Regarding short-term risk, VMD is less volatile compared to TOI. This indicates lower risk in terms of short-term price fluctuations for VMD.Check TOI's competition here
Strata Critical Medical, Inc. (NASDAQ: SRTA)
VMD vs SRTA Comparison September 2026
Viemed Healthcare, Inc. (NASDAQ: VMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMD stands at 345.8M. In comparison, SRTA has a market cap of 460.3M. Regarding current trading prices, VMD is priced at $8.84 on the NASDAQ, while SRTA trades at $5.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMD currently has a P/E ratio of 25.22, whereas SRTA's P/E ratio is -25.08. In terms of profitability, VMD's ROE is +0.10%, compared to SRTA's ROE of +0.14%. Regarding short-term risk, VMD is less volatile compared to SRTA. This indicates lower risk in terms of short-term price fluctuations for VMD.Check SRTA's competition here
Charming Medical Limited Class A Ordinary Shares (NASDAQ: MCTA)
VMD vs MCTA Comparison September 2026
Viemed Healthcare, Inc. (NASDAQ: VMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMD stands at 345.8M. In comparison, MCTA has a market cap of 445.6M. Regarding current trading prices, VMD is priced at $8.84 on the NASDAQ, while MCTA trades at $29.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMD currently has a P/E ratio of 25.22, whereas MCTA's P/E ratio is 419.36. In terms of profitability, VMD's ROE is +0.10%, compared to MCTA's ROE of -2.33%. Regarding short-term risk, VMD is more volatile compared to MCTA. This indicates higher risk in terms of short-term price fluctuations for VMD.Check MCTA's competition here
Community Health Systems, Inc. (NYSE: CYH)
VMD vs CYH Comparison September 2026
Viemed Healthcare, Inc. (NASDAQ: VMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMD stands at 345.8M. In comparison, CYH has a market cap of 407.5M. Regarding current trading prices, VMD is priced at $8.84 on the NASDAQ, while CYH trades at $2.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMD currently has a P/E ratio of 25.22, whereas CYH's P/E ratio is 3.96. In terms of profitability, VMD's ROE is +0.10%, compared to CYH's ROE of +0.21%. Regarding short-term risk, VMD is less volatile compared to CYH. This indicates lower risk in terms of short-term price fluctuations for VMD.Check CYH's competition here
Auna S.A. (NYSE: AUNA)
VMD vs AUNA Comparison September 2026
Viemed Healthcare, Inc. (NASDAQ: VMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMD stands at 345.8M. In comparison, AUNA has a market cap of 390.8M. Regarding current trading prices, VMD is priced at $8.84 on the NASDAQ, while AUNA trades at $5.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMD currently has a P/E ratio of 25.22, whereas AUNA's P/E ratio is 4.76. In terms of profitability, VMD's ROE is +0.10%, compared to AUNA's ROE of +0.01%. Regarding short-term risk, VMD is more volatile compared to AUNA. This indicates higher risk in terms of short-term price fluctuations for VMD.Check AUNA's competition here
Capital Senior Living Corporation (NYSE: CSU)
VMD vs CSU Comparison September 2026
Viemed Healthcare, Inc. (NASDAQ: VMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMD stands at 345.8M. In comparison, CSU has a market cap of 223.7M. Regarding current trading prices, VMD is priced at $8.84 on the NASDAQ, while CSU trades at $33.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMD currently has a P/E ratio of 25.22, whereas CSU's P/E ratio is 0.67. In terms of profitability, VMD's ROE is +0.10%, compared to CSU's ROE of -0.33%. Regarding short-term risk, VMD is less volatile compared to CSU. This indicates lower risk in terms of short-term price fluctuations for VMD.Check CSU's competition here
AirSculpt Technologies, Inc. (NASDAQ: AIRS)
VMD vs AIRS Comparison September 2026
Viemed Healthcare, Inc. (NASDAQ: VMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMD stands at 345.8M. In comparison, AIRS has a market cap of 197.2M. Regarding current trading prices, VMD is priced at $8.84 on the NASDAQ, while AIRS trades at $2.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMD currently has a P/E ratio of 25.22, whereas AIRS's P/E ratio is -93.17. In terms of profitability, VMD's ROE is +0.10%, compared to AIRS's ROE of -0.13%. Regarding short-term risk, VMD is less volatile compared to AIRS. This indicates lower risk in terms of short-term price fluctuations for VMD.Check AIRS's competition here
The Joint Corp. (NASDAQ: JYNT)
VMD vs JYNT Comparison September 2026
Viemed Healthcare, Inc. (NASDAQ: VMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMD stands at 345.8M. In comparison, JYNT has a market cap of 118.6M. Regarding current trading prices, VMD is priced at $8.84 on the NASDAQ, while JYNT trades at $8.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMD currently has a P/E ratio of 25.22, whereas JYNT's P/E ratio is 83.20. In terms of profitability, VMD's ROE is +0.10%, compared to JYNT's ROE of +0.22%. Regarding short-term risk, VMD is less volatile compared to JYNT. This indicates lower risk in terms of short-term price fluctuations for VMD.Check JYNT's competition here
Five Star Senior Living Inc. (NASDAQ: FVE)
VMD vs FVE Comparison September 2026
Viemed Healthcare, Inc. (NASDAQ: VMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMD stands at 345.8M. In comparison, FVE has a market cap of 98.4M. Regarding current trading prices, VMD is priced at $8.84 on the NASDAQ, while FVE trades at $2.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMD currently has a P/E ratio of 25.22, whereas FVE's P/E ratio is -5.64. In terms of profitability, VMD's ROE is +0.10%, compared to FVE's ROE of -0.15%. Regarding short-term risk, VMD is less volatile compared to FVE. This indicates lower risk in terms of short-term price fluctuations for VMD.Check FVE's competition here
Kindly MD, Inc. (NASDAQ: KDLYW)
VMD vs KDLYW Comparison September 2026
Viemed Healthcare, Inc. (NASDAQ: VMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMD stands at 345.8M. In comparison, KDLYW has a market cap of 96.5M. Regarding current trading prices, VMD is priced at $8.84 on the NASDAQ, while KDLYW trades at $18.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMD currently has a P/E ratio of 25.22, whereas KDLYW's P/E ratio is N/A. In terms of profitability, VMD's ROE is +0.10%, compared to KDLYW's ROE of -1.05%. Regarding short-term risk, VMD is less volatile compared to KDLYW. This indicates lower risk in terms of short-term price fluctuations for VMD.Check KDLYW's competition here
Park Dental Partners, Inc. Common Stock (NASDAQ: PARK)
VMD vs PARK Comparison September 2026
Viemed Healthcare, Inc. (NASDAQ: VMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMD stands at 345.8M. In comparison, PARK has a market cap of 92.2M. Regarding current trading prices, VMD is priced at $8.84 on the NASDAQ, while PARK trades at $20.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMD currently has a P/E ratio of 25.22, whereas PARK's P/E ratio is 27.61. In terms of profitability, VMD's ROE is +0.10%, compared to PARK's ROE of -0.18%. Regarding short-term risk, VMD is more volatile compared to PARK. This indicates higher risk in terms of short-term price fluctuations for VMD.Check PARK's competition here
biote Corp. (NASDAQ: BTMD)
VMD vs BTMD Comparison September 2026
Viemed Healthcare, Inc. (NASDAQ: VMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMD stands at 345.8M. In comparison, BTMD has a market cap of 68.1M. Regarding current trading prices, VMD is priced at $8.84 on the NASDAQ, while BTMD trades at $1.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMD currently has a P/E ratio of 25.22, whereas BTMD's P/E ratio is 14.05. In terms of profitability, VMD's ROE is +0.10%, compared to BTMD's ROE of -0.09%. Regarding short-term risk, VMD is less volatile compared to BTMD. This indicates lower risk in terms of short-term price fluctuations for VMD.Check BTMD's competition here
AlerisLife Inc. (NASDAQ: ALR)
VMD vs ALR Comparison September 2026
Viemed Healthcare, Inc. (NASDAQ: VMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMD stands at 345.8M. In comparison, ALR has a market cap of 44.2M. Regarding current trading prices, VMD is priced at $8.84 on the NASDAQ, while ALR trades at $1.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMD currently has a P/E ratio of 25.22, whereas ALR's P/E ratio is -1.11. In terms of profitability, VMD's ROE is +0.10%, compared to ALR's ROE of -0.15%. Regarding short-term risk, VMD is more volatile compared to ALR. This indicates higher risk in terms of short-term price fluctuations for VMD.Check ALR's competition here
DocGo Inc. (NASDAQ: DCGO)
VMD vs DCGO Comparison September 2026
Viemed Healthcare, Inc. (NASDAQ: VMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMD stands at 345.8M. In comparison, DCGO has a market cap of 39.8M. Regarding current trading prices, VMD is priced at $8.84 on the NASDAQ, while DCGO trades at $0.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMD currently has a P/E ratio of 25.22, whereas DCGO's P/E ratio is -0.22. In terms of profitability, VMD's ROE is +0.10%, compared to DCGO's ROE of -1.16%. Regarding short-term risk, VMD is less volatile compared to DCGO. This indicates lower risk in terms of short-term price fluctuations for VMD.Check DCGO's competition here
Cryo-Cell International, Inc. (AMEX: CCEL)
VMD vs CCEL Comparison September 2026
Viemed Healthcare, Inc. (NASDAQ: VMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMD stands at 345.8M. In comparison, CCEL has a market cap of 34.5M. Regarding current trading prices, VMD is priced at $8.84 on the NASDAQ, while CCEL trades at $4.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMD currently has a P/E ratio of 25.22, whereas CCEL's P/E ratio is -14.27. In terms of profitability, VMD's ROE is +0.10%, compared to CCEL's ROE of +0.14%. Regarding short-term risk, VMD is less volatile compared to CCEL. This indicates lower risk in terms of short-term price fluctuations for VMD.Check CCEL's competition here
IMAC Holdings, Inc. (NASDAQ: IMAC)
VMD vs IMAC Comparison September 2026
Viemed Healthcare, Inc. (NASDAQ: VMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMD stands at 345.8M. In comparison, IMAC has a market cap of 33.1M. Regarding current trading prices, VMD is priced at $8.84 on the NASDAQ, while IMAC trades at $1.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMD currently has a P/E ratio of 25.22, whereas IMAC's P/E ratio is -2.27. In terms of profitability, VMD's ROE is +0.10%, compared to IMAC's ROE of +0.00%. Regarding short-term risk, VMD is less volatile compared to IMAC. This indicates lower risk in terms of short-term price fluctuations for VMD.Check IMAC's competition here
P3 Health Partners Inc. (NASDAQ: PIII)
VMD vs PIII Comparison September 2026
Viemed Healthcare, Inc. (NASDAQ: VMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMD stands at 345.8M. In comparison, PIII has a market cap of 30.6M. Regarding current trading prices, VMD is priced at $8.84 on the NASDAQ, while PIII trades at $8.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMD currently has a P/E ratio of 25.22, whereas PIII's P/E ratio is -0.28. In terms of profitability, VMD's ROE is +0.10%, compared to PIII's ROE of +1.61%. Regarding short-term risk, VMD is less volatile compared to PIII. This indicates lower risk in terms of short-term price fluctuations for VMD.Check PIII's competition here
EUDA Health Holdings Limited (NASDAQ: EUDA)
VMD vs EUDA Comparison September 2026
Viemed Healthcare, Inc. (NASDAQ: VMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMD stands at 345.8M. In comparison, EUDA has a market cap of 25.2M. Regarding current trading prices, VMD is priced at $8.84 on the NASDAQ, while EUDA trades at $13.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMD currently has a P/E ratio of 25.22, whereas EUDA's P/E ratio is -25.45. In terms of profitability, VMD's ROE is +0.10%, compared to EUDA's ROE of +1.20%. Regarding short-term risk, VMD is less volatile compared to EUDA. This indicates lower risk in terms of short-term price fluctuations for VMD.Check EUDA's competition here
P3 Health Partners Inc. (NASDAQ: PIIIW)
VMD vs PIIIW Comparison September 2026
Viemed Healthcare, Inc. (NASDAQ: VMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMD stands at 345.8M. In comparison, PIIIW has a market cap of 24.5M. Regarding current trading prices, VMD is priced at $8.84 on the NASDAQ, while PIIIW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMD currently has a P/E ratio of 25.22, whereas PIIIW's P/E ratio is N/A. In terms of profitability, VMD's ROE is +0.10%, compared to PIIIW's ROE of +1.61%. Regarding short-term risk, VMD is more volatile compared to PIIIW. This indicates higher risk in terms of short-term price fluctuations for VMD.Check PIIIW's competition here
Cano Health, Inc. (NYSE: CANO-WT)
VMD vs CANO-WT Comparison September 2026
Viemed Healthcare, Inc. (NASDAQ: VMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMD stands at 345.8M. In comparison, CANO-WT has a market cap of 19.3M. Regarding current trading prices, VMD is priced at $8.84 on the NASDAQ, while CANO-WT trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMD currently has a P/E ratio of 25.22, whereas CANO-WT's P/E ratio is N/A. In terms of profitability, VMD's ROE is +0.10%, compared to CANO-WT's ROE of -1.49%. Regarding short-term risk, VMD is less volatile compared to CANO-WT. This indicates lower risk in terms of short-term price fluctuations for VMD.Check CANO-WT's competition here
Aesthetic Medical International Holdings Group Limited (NASDAQ: AIH)
VMD vs AIH Comparison September 2026
Viemed Healthcare, Inc. (NASDAQ: VMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMD stands at 345.8M. In comparison, AIH has a market cap of 15.9M. Regarding current trading prices, VMD is priced at $8.84 on the NASDAQ, while AIH trades at $0.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMD currently has a P/E ratio of 25.22, whereas AIH's P/E ratio is -2.78. In terms of profitability, VMD's ROE is +0.10%, compared to AIH's ROE of +1.16%. Regarding short-term risk, VMD is less volatile compared to AIH. This indicates lower risk in terms of short-term price fluctuations for VMD.Check AIH's competition here
Cano Health, Inc. (NYSE: CANO)
VMD vs CANO Comparison September 2026
Viemed Healthcare, Inc. (NASDAQ: VMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMD stands at 345.8M. In comparison, CANO has a market cap of 12.4M. Regarding current trading prices, VMD is priced at $8.84 on the NASDAQ, while CANO trades at $2.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMD currently has a P/E ratio of 25.22, whereas CANO's P/E ratio is -0.01. In terms of profitability, VMD's ROE is +0.10%, compared to CANO's ROE of -1.49%. Regarding short-term risk, VMD is less volatile compared to CANO. This indicates lower risk in terms of short-term price fluctuations for VMD.Check CANO's competition here
Avem Health Partners, Inc. (NYSE: FPCG)
VMD vs FPCG Comparison September 2026
Viemed Healthcare, Inc. (NASDAQ: VMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMD stands at 345.8M. In comparison, FPCG has a market cap of 10.1M. Regarding current trading prices, VMD is priced at $8.84 on the NASDAQ, while FPCG trades at $1,025.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMD currently has a P/E ratio of 25.22, whereas FPCG's P/E ratio is 0.09. In terms of profitability, VMD's ROE is +0.10%, compared to FPCG's ROE of +0.00%. Regarding short-term risk, VMD is more volatile compared to FPCG. This indicates higher risk in terms of short-term price fluctuations for VMD.Check FPCG's competition here
Field Trip Health Ltd. (NASDAQ: FTRP)
VMD vs FTRP Comparison September 2026
Viemed Healthcare, Inc. (NASDAQ: VMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMD stands at 345.8M. In comparison, FTRP has a market cap of 9.8M. Regarding current trading prices, VMD is priced at $8.84 on the NASDAQ, while FTRP trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMD currently has a P/E ratio of 25.22, whereas FTRP's P/E ratio is -1.22. In terms of profitability, VMD's ROE is +0.10%, compared to FTRP's ROE of -0.62%. Regarding short-term risk, VMD is less volatile compared to FTRP. This indicates lower risk in terms of short-term price fluctuations for VMD.Check FTRP's competition here
American Shared Hospital Services (AMEX: AMS)
VMD vs AMS Comparison September 2026
Viemed Healthcare, Inc. (NASDAQ: VMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMD stands at 345.8M. In comparison, AMS has a market cap of 9.5M. Regarding current trading prices, VMD is priced at $8.84 on the NASDAQ, while AMS trades at $1.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMD currently has a P/E ratio of 25.22, whereas AMS's P/E ratio is -5.66. In terms of profitability, VMD's ROE is +0.10%, compared to AMS's ROE of -0.07%. Regarding short-term risk, VMD is more volatile compared to AMS. This indicates higher risk in terms of short-term price fluctuations for VMD.Check AMS's competition here
Basel Medical Group Ltd Ordinary Shares (NASDAQ: BMGL)
VMD vs BMGL Comparison September 2026
Viemed Healthcare, Inc. (NASDAQ: VMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMD stands at 345.8M. In comparison, BMGL has a market cap of 7.6M. Regarding current trading prices, VMD is priced at $8.84 on the NASDAQ, while BMGL trades at $4.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMD currently has a P/E ratio of 25.22, whereas BMGL's P/E ratio is -0.91. In terms of profitability, VMD's ROE is +0.10%, compared to BMGL's ROE of -1.74%. Regarding short-term risk, VMD is less volatile compared to BMGL. This indicates lower risk in terms of short-term price fluctuations for VMD.Check BMGL's competition here
20/20 Biolabs Inc. (NASDAQ: AIDX)
VMD vs AIDX Comparison September 2026
Viemed Healthcare, Inc. (NASDAQ: VMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMD stands at 345.8M. In comparison, AIDX has a market cap of 7.2M. Regarding current trading prices, VMD is priced at $8.84 on the NASDAQ, while AIDX trades at $0.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMD currently has a P/E ratio of 25.22, whereas AIDX's P/E ratio is -1.12. In terms of profitability, VMD's ROE is +0.10%, compared to AIDX's ROE of -3.87%. Regarding short-term risk, VMD is less volatile compared to AIDX. This indicates lower risk in terms of short-term price fluctuations for VMD.Check AIDX's competition here
ModivCare Inc. (NASDAQ: MODV)
VMD vs MODV Comparison September 2026
Viemed Healthcare, Inc. (NASDAQ: VMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMD stands at 345.8M. In comparison, MODV has a market cap of 6.2M. Regarding current trading prices, VMD is priced at $8.84 on the NASDAQ, while MODV trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMD currently has a P/E ratio of 25.22, whereas MODV's P/E ratio is -0.06. In terms of profitability, VMD's ROE is +0.10%, compared to MODV's ROE of +1.36%. Regarding short-term risk, VMD is more volatile compared to MODV. This indicates higher risk in terms of short-term price fluctuations for VMD.Check MODV's competition here
Greenbrook TMS Inc. (NASDAQ: GBNH)
VMD vs GBNH Comparison September 2026
Viemed Healthcare, Inc. (NASDAQ: VMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMD stands at 345.8M. In comparison, GBNH has a market cap of 5.5M. Regarding current trading prices, VMD is priced at $8.84 on the NASDAQ, while GBNH trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMD currently has a P/E ratio of 25.22, whereas GBNH's P/E ratio is -0.06. In terms of profitability, VMD's ROE is +0.10%, compared to GBNH's ROE of +15.74%. Regarding short-term risk, VMD is less volatile compared to GBNH. This indicates lower risk in terms of short-term price fluctuations for VMD.Check GBNH's competition here
Starling Oncology Inc. Wt (NASDAQ: STLNW)
VMD vs STLNW Comparison September 2026
Viemed Healthcare, Inc. (NASDAQ: VMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMD stands at 345.8M. In comparison, STLNW has a market cap of 5.3M. Regarding current trading prices, VMD is priced at $8.84 on the NASDAQ, while STLNW trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMD currently has a P/E ratio of 25.22, whereas STLNW's P/E ratio is N/A. In terms of profitability, VMD's ROE is +0.10%, compared to STLNW's ROE of +2.10%. Regarding short-term risk, VMD is less volatile compared to STLNW. This indicates lower risk in terms of short-term price fluctuations for VMD.Check STLNW's competition here
Regional Health Properties, Inc. (AMEX: RHE-PA)
VMD vs RHE-PA Comparison September 2026
Viemed Healthcare, Inc. (NASDAQ: VMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMD stands at 345.8M. In comparison, RHE-PA has a market cap of 5.2M. Regarding current trading prices, VMD is priced at $8.84 on the NASDAQ, while RHE-PA trades at $0.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMD currently has a P/E ratio of 25.22, whereas RHE-PA's P/E ratio is -0.09. In terms of profitability, VMD's ROE is +0.10%, compared to RHE-PA's ROE of +1.09%. Regarding short-term risk, VMD is less volatile compared to RHE-PA. This indicates lower risk in terms of short-term price fluctuations for VMD.Check RHE-PA's competition here
Regional Health Properties, Inc. (AMEX: RHE)
VMD vs RHE Comparison September 2026
Viemed Healthcare, Inc. (NASDAQ: VMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMD stands at 345.8M. In comparison, RHE has a market cap of 5.2M. Regarding current trading prices, VMD is priced at $8.84 on the NASDAQ, while RHE trades at $2.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMD currently has a P/E ratio of 25.22, whereas RHE's P/E ratio is -1.79. In terms of profitability, VMD's ROE is +0.10%, compared to RHE's ROE of -1.31%. Regarding short-term risk, VMD is less volatile compared to RHE. This indicates lower risk in terms of short-term price fluctuations for VMD.Check RHE's competition here
The Oncology Institute, Inc. (NASDAQ: TOIIW)
VMD vs TOIIW Comparison September 2026
Viemed Healthcare, Inc. (NASDAQ: VMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMD stands at 345.8M. In comparison, TOIIW has a market cap of 4.7M. Regarding current trading prices, VMD is priced at $8.84 on the NASDAQ, while TOIIW trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMD currently has a P/E ratio of 25.22, whereas TOIIW's P/E ratio is -0.17. In terms of profitability, VMD's ROE is +0.10%, compared to TOIIW's ROE of +2.10%. Regarding short-term risk, VMD is more volatile compared to TOIIW. This indicates higher risk in terms of short-term price fluctuations for VMD.Check TOIIW's competition here
IMAC Holdings, Inc. (NASDAQ: IMACW)
VMD vs IMACW Comparison September 2026
Viemed Healthcare, Inc. (NASDAQ: VMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMD stands at 345.8M. In comparison, IMACW has a market cap of 1.7M. Regarding current trading prices, VMD is priced at $8.84 on the NASDAQ, while IMACW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMD currently has a P/E ratio of 25.22, whereas IMACW's P/E ratio is N/A. In terms of profitability, VMD's ROE is +0.10%, compared to IMACW's ROE of +0.73%. Regarding short-term risk, VMD is less volatile compared to IMACW. This indicates lower risk in terms of short-term price fluctuations for VMD.Check IMACW's competition here
Endovia Health Sciences, Inc. (AMEX: EDVA)
VMD vs EDVA Comparison September 2026
Viemed Healthcare, Inc. (NASDAQ: VMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMD stands at 345.8M. In comparison, EDVA has a market cap of 1.7M. Regarding current trading prices, VMD is priced at $8.84 on the NASDAQ, while EDVA trades at $0.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMD currently has a P/E ratio of 25.22, whereas EDVA's P/E ratio is N/A. In terms of profitability, VMD's ROE is +0.10%, compared to EDVA's ROE of N/A. Regarding short-term risk, VMD is less volatile compared to EDVA. This indicates lower risk in terms of short-term price fluctuations for VMD.Check EDVA's competition here
EUDA Health Holdings Limited (NASDAQ: EUDAW)
VMD vs EUDAW Comparison September 2026
Viemed Healthcare, Inc. (NASDAQ: VMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMD stands at 345.8M. In comparison, EUDAW has a market cap of 1.1M. Regarding current trading prices, VMD is priced at $8.84 on the NASDAQ, while EUDAW trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMD currently has a P/E ratio of 25.22, whereas EUDAW's P/E ratio is 0.04. In terms of profitability, VMD's ROE is +0.10%, compared to EUDAW's ROE of +1.20%. Regarding short-term risk, VMD is less volatile compared to EUDAW. This indicates lower risk in terms of short-term price fluctuations for VMD.Check EUDAW's competition here
Concord Medical Services Holdings Limited (NYSE: CCM)
VMD vs CCM Comparison September 2026
Viemed Healthcare, Inc. (NASDAQ: VMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMD stands at 345.8M. In comparison, CCM has a market cap of 681.5K. Regarding current trading prices, VMD is priced at $8.84 on the NASDAQ, while CCM trades at $4.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMD currently has a P/E ratio of 25.22, whereas CCM's P/E ratio is -0.31. In terms of profitability, VMD's ROE is +0.10%, compared to CCM's ROE of +0.06%. Regarding short-term risk, VMD is less volatile compared to CCM. This indicates lower risk in terms of short-term price fluctuations for VMD.Check CCM's competition here
NewGenIvf Group Limited (NASDAQ: NIVF)
VMD vs NIVF Comparison September 2026
Viemed Healthcare, Inc. (NASDAQ: VMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMD stands at 345.8M. In comparison, NIVF has a market cap of 72K. Regarding current trading prices, VMD is priced at $8.84 on the NASDAQ, while NIVF trades at $1.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMD currently has a P/E ratio of 25.22, whereas NIVF's P/E ratio is 0.56. In terms of profitability, VMD's ROE is +0.10%, compared to NIVF's ROE of +0.33%. Regarding short-term risk, VMD is less volatile compared to NIVF. This indicates lower risk in terms of short-term price fluctuations for VMD.Check NIVF's competition here
NewGenIvf Group Limited (NASDAQ: NIVFW)
VMD vs NIVFW Comparison September 2026
Viemed Healthcare, Inc. (NASDAQ: VMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMD stands at 345.8M. In comparison, NIVFW has a market cap of 45.7K. Regarding current trading prices, VMD is priced at $8.84 on the NASDAQ, while NIVFW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMD currently has a P/E ratio of 25.22, whereas NIVFW's P/E ratio is -0.01. In terms of profitability, VMD's ROE is +0.10%, compared to NIVFW's ROE of +0.33%. Regarding short-term risk, VMD is more volatile compared to NIVFW. This indicates higher risk in terms of short-term price fluctuations for VMD.Check NIVFW's competition here
Mobile-health Network Solutions Class A Ordinary Shares (NASDAQ: MNDR)
VMD vs MNDR Comparison September 2026
Viemed Healthcare, Inc. (NASDAQ: VMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMD stands at 345.8M. In comparison, MNDR has a market cap of 34.9K. Regarding current trading prices, VMD is priced at $8.84 on the NASDAQ, while MNDR trades at $1.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMD currently has a P/E ratio of 25.22, whereas MNDR's P/E ratio is -0.04. In terms of profitability, VMD's ROE is +0.10%, compared to MNDR's ROE of -0.46%. Regarding short-term risk, VMD is less volatile compared to MNDR. This indicates lower risk in terms of short-term price fluctuations for VMD.Check MNDR's competition here
Talkspace, Inc. (NASDAQ: TALKW)
VMD vs TALKW Comparison September 2026
Viemed Healthcare, Inc. (NASDAQ: VMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMD stands at 345.8M. In comparison, TALKW has a market cap of 33.5K. Regarding current trading prices, VMD is priced at $8.84 on the NASDAQ, while TALKW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMD currently has a P/E ratio of 25.22, whereas TALKW's P/E ratio is 0.00. In terms of profitability, VMD's ROE is +0.10%, compared to TALKW's ROE of +0.00%. Regarding short-term risk, VMD is less volatile compared to TALKW. This indicates lower risk in terms of short-term price fluctuations for VMD.Check TALKW's competition here
DocGo Inc. (NASDAQ: DCGOW)
VMD vs DCGOW Comparison September 2026
Viemed Healthcare, Inc. (NASDAQ: VMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMD stands at 345.8M. In comparison, DCGOW has a market cap of 0. Regarding current trading prices, VMD is priced at $8.84 on the NASDAQ, while DCGOW trades at $1.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMD currently has a P/E ratio of 25.22, whereas DCGOW's P/E ratio is N/A. In terms of profitability, VMD's ROE is +0.10%, compared to DCGOW's ROE of -1.16%. Regarding short-term risk, VMD is less volatile compared to DCGOW. This indicates lower risk in terms of short-term price fluctuations for VMD.Check DCGOW's competition here
Tivity Health, Inc. (NASDAQ: TVTY)
VMD vs TVTY Comparison September 2026
Viemed Healthcare, Inc. (NASDAQ: VMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMD stands at 345.8M. In comparison, TVTY has a market cap of 0. Regarding current trading prices, VMD is priced at $8.84 on the NASDAQ, while TVTY trades at $32.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMD currently has a P/E ratio of 25.22, whereas TVTY's P/E ratio is 19.06. In terms of profitability, VMD's ROE is +0.10%, compared to TVTY's ROE of +1.75%. Regarding short-term risk, VMD is more volatile compared to TVTY. This indicates higher risk in terms of short-term price fluctuations for VMD.Check TVTY's competition here
ATI Physical Therapy, Inc. (NYSE: ATIP-WT)
VMD vs ATIP-WT Comparison September 2026
Viemed Healthcare, Inc. (NASDAQ: VMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMD stands at 345.8M. In comparison, ATIP-WT has a market cap of 0. Regarding current trading prices, VMD is priced at $8.84 on the NASDAQ, while ATIP-WT trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMD currently has a P/E ratio of 25.22, whereas ATIP-WT's P/E ratio is N/A. In terms of profitability, VMD's ROE is +0.10%, compared to ATIP-WT's ROE of +2.05%. Regarding short-term risk, VMD is less volatile compared to ATIP-WT. This indicates lower risk in terms of short-term price fluctuations for VMD.Check ATIP-WT's competition here
New Frontier Health Corporation (NYSE: NFH)
VMD vs NFH Comparison September 2026
Viemed Healthcare, Inc. (NASDAQ: VMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMD stands at 345.8M. In comparison, NFH has a market cap of 0. Regarding current trading prices, VMD is priced at $8.84 on the NASDAQ, while NFH trades at $11.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMD currently has a P/E ratio of 25.22, whereas NFH's P/E ratio is -19.75. In terms of profitability, VMD's ROE is +0.10%, compared to NFH's ROE of -0.06%. Regarding short-term risk, VMD is more volatile compared to NFH. This indicates higher risk in terms of short-term price fluctuations for VMD.Check NFH's competition here
Diversicare Healthcare Services, Inc. (NASDAQ: DVCR)
VMD vs DVCR Comparison September 2026
Viemed Healthcare, Inc. (NASDAQ: VMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMD stands at 345.8M. In comparison, DVCR has a market cap of 0. Regarding current trading prices, VMD is priced at $8.84 on the NASDAQ, while DVCR trades at $10.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMD currently has a P/E ratio of 25.22, whereas DVCR's P/E ratio is 28.34. In terms of profitability, VMD's ROE is +0.10%, compared to DVCR's ROE of -0.15%. Regarding short-term risk, VMD is more volatile compared to DVCR. This indicates higher risk in terms of short-term price fluctuations for VMD.Check DVCR's competition here
SOC Telemed, Inc. (NASDAQ: TLMDW)
VMD vs TLMDW Comparison September 2026
Viemed Healthcare, Inc. (NASDAQ: VMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMD stands at 345.8M. In comparison, TLMDW has a market cap of 0. Regarding current trading prices, VMD is priced at $8.84 on the NASDAQ, while TLMDW trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMD currently has a P/E ratio of 25.22, whereas TLMDW's P/E ratio is N/A. In terms of profitability, VMD's ROE is +0.10%, compared to TLMDW's ROE of -0.46%. Regarding short-term risk, VMD is less volatile compared to TLMDW. This indicates lower risk in terms of short-term price fluctuations for VMD.Check TLMDW's competition here
Skylight Health Group Inc. (NASDAQ: SLHGP)
VMD vs SLHGP Comparison September 2026
Viemed Healthcare, Inc. (NASDAQ: VMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMD stands at 345.8M. In comparison, SLHGP has a market cap of 0. Regarding current trading prices, VMD is priced at $8.84 on the NASDAQ, while SLHGP trades at $12.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMD currently has a P/E ratio of 25.22, whereas SLHGP's P/E ratio is -30.38. In terms of profitability, VMD's ROE is +0.10%, compared to SLHGP's ROE of -0.48%. Regarding short-term risk, VMD is more volatile compared to SLHGP. This indicates higher risk in terms of short-term price fluctuations for VMD.Check SLHGP's competition here
Hanger, Inc. (NYSE: HNGR)
VMD vs HNGR Comparison September 2026
Viemed Healthcare, Inc. (NASDAQ: VMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMD stands at 345.8M. In comparison, HNGR has a market cap of 0. Regarding current trading prices, VMD is priced at $8.84 on the NASDAQ, while HNGR trades at $18.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMD currently has a P/E ratio of 25.22, whereas HNGR's P/E ratio is 19.71. In terms of profitability, VMD's ROE is +0.10%, compared to HNGR's ROE of +0.52%. Regarding short-term risk, VMD is more volatile compared to HNGR. This indicates higher risk in terms of short-term price fluctuations for VMD.Check HNGR's competition here
Almost Family Inc. (NASDAQ: AFAM)
VMD vs AFAM Comparison September 2026
Viemed Healthcare, Inc. (NASDAQ: VMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMD stands at 345.8M. In comparison, AFAM has a market cap of 0. Regarding current trading prices, VMD is priced at $8.84 on the NASDAQ, while AFAM trades at $56.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMD currently has a P/E ratio of 25.22, whereas AFAM's P/E ratio is N/A. In terms of profitability, VMD's ROE is +0.10%, compared to AFAM's ROE of +0.06%. Regarding short-term risk, VMD is less volatile compared to AFAM. This indicates lower risk in terms of short-term price fluctuations for VMD.Check AFAM's competition here
SOC Telemed, Inc. (NASDAQ: TLMD)
VMD vs TLMD Comparison September 2026
Viemed Healthcare, Inc. (NASDAQ: VMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMD stands at 345.8M. In comparison, TLMD has a market cap of 0. Regarding current trading prices, VMD is priced at $8.84 on the NASDAQ, while TLMD trades at $3.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMD currently has a P/E ratio of 25.22, whereas TLMD's P/E ratio is -1.60. In terms of profitability, VMD's ROE is +0.10%, compared to TLMD's ROE of -0.46%. Regarding short-term risk, VMD is more volatile compared to TLMD. This indicates higher risk in terms of short-term price fluctuations for VMD.Check TLMD's competition here
Kindred Healthcare, Inc. (NYSE: KND)
VMD vs KND Comparison September 2026
Viemed Healthcare, Inc. (NASDAQ: VMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMD stands at 345.8M. In comparison, KND has a market cap of 0. Regarding current trading prices, VMD is priced at $8.84 on the NASDAQ, while KND trades at $9.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMD currently has a P/E ratio of 25.22, whereas KND's P/E ratio is -1.14. In terms of profitability, VMD's ROE is +0.10%, compared to KND's ROE of -0.53%. Regarding short-term risk, VMD is more volatile compared to KND. This indicates higher risk in terms of short-term price fluctuations for VMD.Check KND's competition here
Skylight Health Group Inc. (NASDAQ: SLHG)
VMD vs SLHG Comparison September 2026
Viemed Healthcare, Inc. (NASDAQ: VMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VMD stands at 345.8M. In comparison, SLHG has a market cap of 0. Regarding current trading prices, VMD is priced at $8.84 on the NASDAQ, while SLHG trades at $0.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VMD currently has a P/E ratio of 25.22, whereas SLHG's P/E ratio is -1.48. In terms of profitability, VMD's ROE is +0.10%, compared to SLHG's ROE of N/A. Regarding short-term risk, VMD is less volatile compared to SLHG. This indicates lower risk in terms of short-term price fluctuations for VMD.Check SLHG's competition here